Liver iron concentrations and urinary hepcidin in β-thalassemia

Haematologica

Volumn 92, Issue 5, 2007, Pages 583-588

  Origa, Raffaella ^a   Galanello, Renzo ^a   Ganz, Tomas ^b   Giagu, Nicolina ^a   Maccioni, Liliana ^a   Faa, Gavino ^a   Nemeth, Elizabeta ^b,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatic iron; Ineffective erythropoiesis; Iron absorption; Iron loading anemia

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEPCIDIN; IRON; TRANSFERRIN RECEPTOR; ANTIMICROBIAL CATIONIC PEPTIDE; DEFEROXAMINE; IRON CHELATING AGENT; TRANSFERRIN;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FERRITIN BLOOD LEVEL; GENE ACTIVITY; GENE FUNCTION; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER; LIVER BIOPSY; MALE; PATHOGENESIS; ADOLESCENT; BLOOD; CHELATION THERAPY; CHEMISTRY; COMPARATIVE STUDY; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; INTESTINE ABSORPTION; IRON INTAKE; MACROPHAGE; METABOLISM; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; SECRETION; URINE;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; COMBINED MODALITY THERAPY; DEFEROXAMINE; ERYTHROPOIESIS; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL ABSORPTION; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; IRON, DIETARY; LIVER; MACROPHAGES; MALE; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 34447306076     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10842     Document Type: Article

References (25)

1. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in β-thalassaemia intermedia. Lancet 1979;2:819-21.
2. Pootrakul P, Kitcharoen K, Yansukon F, Wasi P, Fucharoen S, Charoenlarp P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988;71:1124-9.
3. Olivieri NF. The β-thalassemias. N Engl J Med 1999;341:99-109.
4. Taner A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006;37:12-20.
5. Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med 2005; 353: 1135-46.
6. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91:727-32.
7. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood 2005; 105: 4103-5.
8. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007;48:57-63.
9. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, et al. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 2004;124:123-4.
10. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006;26:323-42.
11. Sciot R, Van EP, Facchetti F, Callea F, van der SK, van DH, et al. Hepatocellular transferrin receptor expression in secondary siderosis. Liver 1989;9:52-61.
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
13. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6.
14. Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 1993;42:81-5.
15. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995;89:757-61.
16. Fiorelli G, Fargion S, Piperno A, Battafarano N, Cappellini MD. Iron metabolism in thalassemia intermedia. Haematologica 1990;75 Suppl 5:89-95.
17. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-44.
18. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-9.
19. Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F, Galani A, Ladis V, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006;91:809-12.
20. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006; 55: 667-74.
21. Roy CN, Weinstein DA, Andrews NC. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res 2003;53:507-12.
22. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
23. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005;106:3979-84.
24. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. Best Pract Res Clin Haematol 2005;18:251-63.
25. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005;105:1803-6.